Drug Res (Stuttg) 2016; 66(10): 532-538
DOI: 10.1055/s-0042-111200
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

In Silico and In Vitro Evaluation of Cytotoxic Activities of Farnesiferol C and Microlobin on MCF-7, HeLa and KYSE Cell Lines

L. Aldaghi
1   Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
,
A. Rad
1   Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
,
A. Arab
2   Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
,
J. Kasaian
3   Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran
,
M. Iranshahi
2   Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
,
A. S. Sadr
4   Bioinformatics Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
5   Bioinformatics Research Center, Cheragh Medical institute & Hospital, Kabul, Afghanistan
,
F. Soltani
2   Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1   Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
› Author Affiliations
Further Information

Publication History

received 06 April 2016

accepted 24 June 2016

Publication Date:
27 July 2016 (online)

Abstract

Background: Cancer is one of the leading causes of death worldwide. Despite certain advances in cancer therapy, still there is considerable demand for developing efficient therapeutic agents. Nowadays, there is a rising interest in the use of natural-based anti-cancer drugs. In this study, the cytotoxicity of farnesiferol C and microlobin isolated from Ferula szowitsiana was investigated against MCF-7, HeLa and KYSE cancer cell lines. In addition, the mechanism of binding of these compounds to apoptotic proteins (Bax, Bak and Bcl-2) was analyzed by an in silico method.

Materials and methods: We used MTT assay in order to assess the cytotoxicity of compounds against cancer cell lines. For in silico study, the AutoDock 4 was adopted.

Results and discussion: According to the in vitro findings, in general, farnesiferol C showed significant cytotoxicity at higher concentrations (>50 µM) following 48 and 72 h incubation with the selected cancer cells; however, microlobin exhibited almost no activity at concentrations up to 100 µM. The in silico results revealed that both compounds could bind to Bax more efficiently rather than to Bcl-2 or Bak proteins.

Conclusion: The results obtained by our preliminary in vitro and in silico studies suggest that these compounds might induce apoptosis through Bax activation; however further studies, either in vitro or in vivo are needed to clarify these activities.

 
  • References

  • 1 Soltanzad SS, Barar J, Nazemyieh H et al. Evaluation of cytotoxicity and anti-cancer effect of Ferula szowitsiana methanolic extract on lung cancer A549 cell-lines. Res Pharm Sci 2012; 7: S103
  • 2 Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
  • 3 Abd El-Razek MH, Ohta S, Ahmed AA et al. Sesquiterpene coumarins from the roots of Ferula assa-foetida. Phytochemistry 2001; 58: 1289-1295
  • 4 Iranshahi M, Arfa P, Ramezani M et al. Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry 2007; 68: 554-561
  • 5 Zhou P, Takaishi Y, Duan H et al. Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release. Phytochemistry 2000; 53: 689-697
  • 6 Valle MG, Appendino G, Nano GM et al. Prenylated coumarins and sesquiterpenoids from Ferula communis. Phytochemistry 1986; 26: 253-256
  • 7 Iranshahi M, Amin G, Shafiee A. A new coumarin from Ferula persica. Pharm Biol 2004; 42: 440-442
  • 8 Iranshahi M, Amin G-R, Jalalizadeh H et al. New germacrane derivative from Ferula persica. Pharm Biol 2003; 41: 431-433
  • 9 Iranshahi M, Amin G-R, Amini M et al. Sulfur containing derivatives from Ferula persica var. latisecta. Phytochemistry 2003; 63: 965-966
  • 10 Iranshahi M. A review of volatile sulfur-containing compounds from terrestrial plants: biosynthesis, distribution and analytical methods. J Essent Oil Res 2012; 24: 393-434
  • 11 Nazari ZE, Iranshahi M. Biologically active sesquiterpene coumarins from Ferula species. Phytother Res 2011; 25: 315-323
  • 12 Lee J-H, Choi S, Lee Y et al. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades. Mol cancer Ther 2010; 9: 389-399
  • 13 Nabiev AA, Malikov VM. Microlobin — A new coumarin fromFerula microloba. Chem Nat Compd 1983; 19: 664-667
  • 14 Zhao G, Zhu Y, Eno CO et al. Activation of the proapoptotic Bcl-2 protein Bax by a small molecule induces tumor cell apoptosis. Mol Cell Biol 2014; 34: 1198-1207
  • 15 Sivakumar D, Richa T, Siva Rajesh S et al. In silico methods for designing antagonists to anti-apoptotic members of Bcl-2 family proteins. Mini Rev Med Chem 2012; 12: 1144-1153
  • 16 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
  • 17 Bagheri SM, Sahebkar A, Gohari AR et al. Evaluation of cytotoxicity and anticonvulsant activity of some Iranian medicinal Ferula species. Pharm Biol 2010; 48: 242-246
  • 18 Hajimehdipoor H, Esmaeili S, Ramezani R et al. The cytotoxic effects of Ferula persica var. persica and Ferula hezarlalehzarica against HepG2, A549, HT29, MCF7 and MDBK cell lines. Iran J Pharm Sci 2012; 8: 113-117
  • 19 Dastan D, Salehi P, Gohari AR et al. Bioactive Sesquiterpene Coumarins from. Planta Med 2014; 80: 1118-1123
  • 20 Hanafi-Bojd MY, Iranshahi M, Mosaffa F et al. Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. Planta Medica 2011; 77: 1590-1593
  • 21 Shahneh FZ, Valiyari S, Azadmehr A et al. Inhibition of Growth and Induction of Apoptosis in Fibrosarcoma Cell Lines by Echinophora platyloba DC: In Vitro Analysis. Adv Pharmacol Sci 2013; 2013: 512931
  • 22 Kepp O, Galluzzi L, Lipinski M et al. Cell death assays for drug discovery. Nat Rev Drug Discov 2011; 10: 221-237
  • 23 Xu H, Tang W, Du G et al. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discov Ther 2011; 5: 202-210
  • 24 Desagher S, Martinou J-C. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369-377
  • 25 Liu D, Huang Z. Synthetic peptides and non-peptidic molecules as probes of structure and function of Bcl-2 family proteins and modulators of apoptosis. Apoptosis 2001; 6: 453-462
  • 26 Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?. Genes to Cells 1998; 3: 697-707
  • 27 Iyer S, Anwari K, Alsop AE et al. Identification of an activation site in Bak and mitochondrial Bax triggered by antibodies. Nat Commun 2016; 7: 11734
  • 28 Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000; 103: 645-654